World’s first mRNA cancer jab for melanoma cuts risk of death by 42%

The study included more than 1,100 people with high-risk melanoma that had been surgically removed.

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.standard.co.uk)